Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

05/02/2021 08:00

Feb 5 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2020        Dec 31, 2019     Mar 31, 2021 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            160 mln             161 mln                    
                 (-0.9 pct)          (-34.8 pct)                  
  Operating       loss 1.27           loss 1.74                   
  Recurring       loss 1.26           loss 1.74                   
  Net             loss 1.18           loss 1.78                   
  EPS           loss 6.71 yen      loss 11.16 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T